Sanford Hillsberg Insider Trading
Get free email notifications about insider trading for Sanford Hillsberg.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Sanford Hillsberg. Sanford Hillsberg is a 10% Owner in Cordex Pharma, Inc. ($DSKT) and a Secretary in Cordex Pharma, Inc. ($DSKT) and a Director in Galena Biopharma, Inc. ($GALE) and a Director in Lion Biotechnologies, Inc. ($LBIO).
Address: 1801 CENTURY PARK EAST LOS ANGELES 90067 CA
Companies in which Sanford Hillsberg is an Insider
Cordex Pharma, Inc.
Trading Symbol: DSKTIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Sanford Hillsberg: 10% Owner, Secretary
Holdings: 3,158,000 shares
Latest Transaction: Jan 05 2007
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
IOVANCE BIOTHERAPEUTICS, INC.
Trading Symbol: IOVAIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Sanford Hillsberg: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jan 29 2015
$IOVA Market Capitalization: $437.71M
$IOVA Previous Close: $7.10
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
SELLAS Life Sciences Group, Inc.
Trading Symbol: SLSIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Sanford Hillsberg: Director
Holdings: 95,447 shares
Current Value: $133,626
Latest Transaction: Jan 31 2014
$SLS Market Capitalization: $9.04M
$SLS Previous Close: $1.40
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Sanford Hillsberg
Sentiment: All, DSKT, IOVA, SLS
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 29 2015 | LBIO | Lion Biotechnologi ... | Hillsberg Sanford | Director | Option Exercise | J | 2.50 | 25,000 | 62,500 | 0 | |
Jan 29 2015 | LBIO | Lion Biotechnologi ... | Hillsberg Sanford | Director | Option Exercise | A | 2.50 | 25,000 | 62,500 | 25,000 | |
Jan 29 2015 | LBIO | Lion Biotechnologi ... | Hillsberg Sanford | Director | Sell | J | 0.00 | 25,000 | 0 | 0 | 25 K to 0 (-100.00 %) |
Jan 29 2015 | LBIO | Lion Biotechnologi ... | Hillsberg Sanford | Director | Grant | A | 0.00 | 25,000 | 0 | 25,000 | 0 to 25 K |
Mar 05 2014 | LBIO | Lion Biotechnologi ... | Hillsberg Sanford | Director | Option Exercise | A | 5.65 | 40,000 | 226,000 | 40,000 | |
Jan 16 2014 | LBIO | Lion Biotechnologi ... | Hillsberg Sanford | Director | Grant | A | 0.00 | 67,500 | 0 | 269,000 | 201.5 K to 269 K (+33.50 %) |
Jan 31 2014 | GALE | Galena Biopharma, ... | Hillsberg Sanford | Director | Option Exercise | H | 1.71 | 50,000 | 85,500 | 0 |